MPLT
MapLight Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$13.77
+4.79%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.20x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.01x
- Net debt / EBITDA
- 0.30x
Liquidity & coverage
- Current ratio
- 16.52x
- Quick ratio
- 16.52x
- Cash ratio
- 15.79x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $299.5M
Cash & dividend
- FCF / debt
- -88.13x
- Cash flow / debt
- -87.91x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026